I mean, why have a drug regulatory system when youre going to constantly come up with exceptions? Zuckerman notes that some peptides, like the GLP-1 drugs, have been approved by the FDA
Telehealth is a practical first step for many people
Its revelations challenge stakeholders to innovate and collaborate across sectors to ensure that progress in pharmaceutical development translates into equitable health benefits for all populations grappling with diabetes and obesity
The likelihood of weight regain varies among individuals
For example, semaglutide users used more insulin, had higher HgA1cs and had higher eGFR
This finding in women is consistent with prior reports suggesting that GLP-1 RAs may produce more pronounced weight loss and glycemic improvements in female people, potentially due to sex-specific differences in GLP-1 receptor expression, pharmacodynamics, or hormonal interactions [21]